サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1741992

欧州の非侵襲性換気マスク市場の予測 (2031年まで) - 地域別分析 (製品別、用途別、エンドユーザー別)

Europe Non-Invasive Ventilation Masks Market Forecast to 2031 - Regional Analysis - by Product, Application, and End User

出版日
ページ情報
英文 147 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.90円
欧州の非侵襲性換気マスク市場の予測 (2031年まで) - 地域別分析 (製品別、用途別、エンドユーザー別)
出版日: 2025年03月11日
発行: The Insight Partners
ページ情報: 英文 147 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の非侵襲性換気マスク市場は2023年に5億7,458万米ドルと評価され、2031年には9億2,202万米ドルに達すると予測され、2023年から2031年までのCAGRは6.1%と推定されます。

在宅医療志向の高まりが、欧州の非侵襲性換気マスク市場を牽引

長期療養施設、入院リハビリテーション施設、熟練看護施設から在宅療養環境へとシフトすることで、クラウドやモビリティ主導型の医療機器により、患者と医師とのより良い、一貫性のある、タイムリーな相互作用がもたらされます。COVID-19の流行は、病院の病床数の制限と熟練した医療専門家の不足のため、在宅医療の重要性を誘発しました。在宅医療の助けを借りて、医療専門家は患者のバイタルを遠隔でモニターし、入院を避けることができます。

さらに、COPD、睡眠時無呼吸症候群、その他の呼吸器系疾患を抱える患者が、自宅での管理を希望するケースが増えています。患者は頻繁に病院を訪れることなく、自宅で快適にNIV療法を受けることができます。在宅医療プロバイダーは、包括的な呼吸ケアプランの構成要素として、NIVマスクを処方する頻度を高めています。

そのため、在宅医療への牽引力の高まりと、より高度で手頃な価格の、簡単に操作できる在宅用デバイスへの需要の高まりにより、非侵襲性換気マスクの市場は顕著な牽引力を増しています。

欧州の非侵襲性換気マスク市場の概要

欧州の非侵襲性換気マスク市場は、ドイツ、フランス、英国、イタリア、スペイン、その他欧州に区分されます。この地域市場を牽引しているのは、COPD、OSA、急性呼吸不全（ARF）などの慢性呼吸器疾患の有病率の増加、欧州の非侵襲性換気マスク市場におけるPhilips、Intersurgical、Hamilton Medicalなどの有力企業の存在、NIVマスクメーカーによる戦略的開発などです。2020年6月、医療技術企業のReddyPort社は、NIVの成功をサポートし、臨床医が換気マスクを通して処置を行うことを可能にするソリューションであるReddyPort ElbowのCEマーク承認を取得しました。この製品承認により、同社は欧州連合（EU）をはじめ、ルーマニア、スペイン、フランス、オーストリアなどCEマーク取得地域全域での商品化が可能となりました。

欧州の非侵襲性換気マスク市場の収益と2031年までの予測（金額）

欧州の非侵襲性換気マスク市場のセグメンテーション

欧州の非侵襲性換気マスク市場は、製品、用途、エンドユーザー、国に分類されます。

製品別では、欧州の非侵襲性換気マスク市場は、使い捨て型非侵襲性換気マスクとアイ利用型非侵襲性換気マスクに二分されます。2023年の欧州の非侵襲性換気マスク市場シェアは、使い捨て型非侵襲性換気マスク分野が大きなシェアを占めています。

用途別では、欧州の非侵襲性換気マスク市場は、睡眠時無呼吸、慢性閉塞性肺疾患、肺炎、その他に区分されます。2023年の欧州非侵襲性換気マスク市場シェアでは、睡眠時無呼吸分野が最大シェアを占めています。

エンドユーザー別に見ると、欧州の非侵襲性換気マスク市場は病院・診療所、在宅医療、その他に区分されます。2023年の欧州非侵襲性換気マスク市場シェアでは、病院・診療所セグメントが最大シェアを占めています。

国別に見ると、欧州の非侵襲性換気マスク市場は、英国、ドイツ、フランス、イタリア、スペイン、その他欧州に区分されます。ドイツが2023年の欧州非侵襲性換気マスク市場で最大のシェアを占めています。

Air Liquide Medical Systems;Armstrong Medical Ltd;Besmed Health Business Corp;BMC Medical Co Ltd;DeVilbiss Healthcare LLC;Dimar S.P.A;Dragerwerk AG &Co KGaA;Fisher &Paykel Healthcare Corp Ltd;Hamilton Medical AG;Hangzhou Formed Medical Devices Co., Ltd;Intersurgical Ltd;Koninklijke Philips NV;Medline Industries LP;ResMed Inc;Sleepnet Corporation;SunMed Group Holdings LLC（AirLife）;and SURU INTERNATIONAL PVT.LTD.などが、欧州の非侵襲性換気マスク市場で事業を展開している主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要洞察

第3章 分析手法

  • 二次調査
  • 一次調査
    • 仮説の策定
    • マクロ経済要因分析
    • 基礎数値の開発
    • データの三角測量
    • 国レベルのデータ

第4章 欧州の非侵襲性換気マスク市場の情勢

  • PEST分析

第5章 欧州の非侵襲性換気マスク市場：主要な市場力学

  • 欧州の非侵襲性換気マスク市場：主要な市場力学
  • 市場促進要因
    • 呼吸器疾患の有病率の増加
    • 在宅医療志向の高まり
  • 市場抑制要因
    • NIVマスクに伴う副作用
  • 市場機会
    • NIVマスクの採用増加
  • 今後の動向
    • 技術進歩の進展
  • 促進要因と抑制要因の影響

第6章 欧州の非侵襲性換気マスク市場の分析

  • 非侵襲性換気マスク市場の収益 (2021～2031年)
  • 非侵襲性換気マスク市場の予測・分析

第7章 欧州の非侵襲性換気マスク市場の分析：製品別

  • 使い捨て型非侵襲性換気マスク
  • 再利用型非侵襲性換気マスク

第8章 欧州の非侵襲性換気マスク市場の分析：用途別

  • 睡眠時無呼吸症候群
  • 慢性閉塞性肺疾患
  • 肺炎
  • その他

第9章 欧州の非侵襲性換気マスク市場の分析：エンドユーザー別

  • 病院・診療所
  • 在宅医療
  • その他

第10章 欧州の非侵襲性換気マスク市場：国別分析

  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • その他欧州

第11章 業界情勢

  • 非侵襲性換気マスク市場の成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第12章 企業プロファイル

  • Hamilton Medical AG
  • ResMed Inc
  • Fisher & Paykel Healthcare Corp Ltd
  • Air Liquide Medical Systems
  • Dragerwerk AG & Co KGaA
  • Intersurgical Ltd
  • BMC Medical Co Ltd
  • DeVilbiss Healthcare LLC
  • Armstrong Medical Ltd
  • Koninklijke Philips NV
  • Besmed Health Business Corp
  • Sleepnet Corporation.
  • SunMed Group Holdings LLC（AirLife）
  • Dimar S.P.A.
  • Hangzhou Formed Medical Devices Co., Ltd
  • SURU INTERNATIONAL PVT. LTD.
  • Medline Industries LP

第13章 付録

図表

List Of Tables

  • Table 1. Europe Non-Invasive Ventilation Masks Market Segmentation
  • Table 2. Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Product
  • Table 4. Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application
  • Table 5. Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million) - by End User
  • Table 6. Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 7. United Kingdom: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
  • Table 8. United Kingdom: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 9. United Kingdom: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 10. Germany: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
  • Table 11. Germany: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 12. Germany: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 13. France: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
  • Table 14. France: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 15. France: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 16. Italy: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
  • Table 17. Italy: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 18. Italy: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 19. Spain: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
  • Table 20. Spain: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 21. Spain: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 22. Rest of Europe: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
  • Table 23. Rest of Europe: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 24. Rest of Europe: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 25. Recent Organic Growth Strategies in Noninvasive Ventilation Mask Market
  • Table 26. Recent Inorganic Growth Strategies in the Noninvasive Ventilation Mask Market
  • Table 27. List of Abbreviations
  • Table 28. Abbreviation

List Of Figures

  • Figure 1. Europe Non-Invasive Ventilation Masks Market Segmentation - Country
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Non-Invasive Ventilation Masks Market Revenue (US$ Million), 2021-2031
  • Figure 5. Europe Non-Invasive Ventilation Masks Market Share (%) - by Product (2023 and 2031)
  • Figure 6. Non-Invasive Ventilation Disposable Mask: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 7. Non-Invasive Ventilation Reusable Mask: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Europe Non-Invasive Ventilation Masks Market Share (%) - by Application (2023 and 2031)
  • Figure 9. Sleep Apnea: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Chronic Obstructive Pulmonary Disease: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. Pneumonia: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 12. Others: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Europe Non-Invasive Ventilation Masks Market Share (%) - by End User (2023 and 2031)
  • Figure 14. Hospitals and Clinics: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 15. Home Care: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 16. Others: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 17. Europe Non-Invasive Ventilation Masks Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 18. United Kingdom: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 19. Germany: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 20. France: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 21. Italy: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 22. Spain: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 23. Rest of Europe: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 24. Growth Strategies in Noninvasive Ventilation Mask Market
目次
Product Code: TIPRE00028768

The Europe non-invasive ventilation masks market was valued at US$ 574.58 million in 2023 and is expected to reach US$ 922.02 million by 2031; it is estimated to register a CAGR of 6.1% from 2023 to 2031.

Growing Inclination Towards Home Healthcare Drive Europe Cosmetic Preservatives Market

A shift from long-term facilities, inpatient rehabilitation, and skilled nursing facilities to home care settings results in a better, consistent, and timely interaction between patient and doctor owing to the cloud and mobility-driven medical devices. The COVID-19 outbreak triggered home healthcare's importance due to limited hospital bed capacity and a scarcity of skilled healthcare professionals. With the help of home healthcare, healthcare professionals can monitor patient's vitals remotely and avoid hospital admissions.

Moreover, patients with conditions such as COPD, sleep apnea, and other respiratory issues are increasingly expressing a preference for at-home management of their ailments. Patients can use NIV therapy in the comfort of their homes without having to make frequent visits to the hospital. Home healthcare providers are prescribing NIV masks more frequently as a component of all-encompassing respiratory care plans.

Therefore, due to the growing traction toward home healthcare and increasing demand for more advanced, affordable, and easily navigable devices at home, the market for Noninvasive ventilation masks is gaining noticeable traction.

Europe Cosmetic Preservatives Market Overview

The Europe noninvasive ventilation masks market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. The regional market is driven due to the increasing prevalence of chronic respiratory diseases, including COPD, OSA, acute respiratory failure (ARF), the presence of prominent players such as Philips, Intersurgical, and Hamilton Medical in the Europe noninvasive ventilation masks market, and strategic developments made by NIV masks manufacturers. In June 2020, ReddyPort, a medical technology company, received CE Mark approval for ReddyPort Elbow, a solution that supports NIV success and allows clinicians to perform procedures through the ventilation mask. This product approval allows the company to commercialize it across the European Union and other CE Mark geographies, including Romania, Spain, France, and Austria.

Europe Cosmetic Preservatives Market Revenue and Forecast to 2031 (US$ Million)

Europe Cosmetic Preservatives Market Segmentation

The Europe non-invasive ventilation masks market is categorized into product, application, end user, and country.

By product, the Europe non-invasive ventilation masks market is bifurcated into noninvasive ventilation disposable mask and noninvasive ventilation reusable mask. The noninvasive ventilation disposable mask segment held a larger share of the Europe non-invasive ventilation masks market share in 2023.

In terms of application, the Europe non-invasive ventilation masks market is segmented into sleep apnea, chronic obstructive pulmonary disease, pneumonia, and others. The sleep apnea segment held the largest share of the Europe non-invasive ventilation masks market share in 2023.

Based on end user, the Europe non-invasive ventilation masks market is segmented into hospitals and clinics, home care, and others. The hospitals and clinics segment held the largest share of the Europe non-invasive ventilation masks market share in 2023.

Based on country, the Europe non-invasive ventilation masks market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany segment held the largest share of Europe non-invasive ventilation masks market in 2023.

Air Liquide Medical Systems; Armstrong Medical Ltd; Besmed Health Business Corp; BMC Medical Co Ltd; DeVilbiss Healthcare LLC; Dimar S.P.A.; Dragerwerk AG & Co KGaA; Fisher & Paykel Healthcare Corp Ltd; Hamilton Medical AG; Hangzhou Formed Medical Devices Co., Ltd; Intersurgical Ltd; Koninklijke Philips NV; Medline Industries LP; ResMed Inc; Sleepnet Corporation; SunMed Group Holdings LLC ( AirLife); and SURU INTERNATIONAL PVT. LTD. are some of the leading companies operating in the Europe non-invasive ventilation masks market.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Europe Non-Invasive Ventilation Masks Market Landscape

  • 4.1 PEST Analysis

5. Europe Non-Invasive Ventilation Masks Market - Key Market Dynamics

  • 5.1 Europe Non-Invasive Ventilation Masks Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increasing Prevalence of Respiratory Diseases
    • 5.2.2 Growing Inclination Towards Home Healthcare
  • 5.3 Market Restraints
    • 5.3.1 Side Effects Associated with NIV Masks
  • 5.4 Market Opportunities
    • 5.4.1 Increasing Adoption of NIV Masks
  • 5.5 Future Trends
    • 5.5.1 Rising Technological Advancements
  • 5.6 Impact of Drivers and Restraints:

6. Europe Non-Invasive Ventilation Masks Market - Analysis

  • 6.1 Europe Non-Invasive Ventilation Masks Market Revenue (US$ Million), 2021-2031
  • 6.2 Europe Non-Invasive Ventilation Masks Market Forecast Analysis

7. Europe Non-Invasive Ventilation Masks Market Analysis - by Product

  • 7.1 Non-Invasive Ventilation Disposable Mask
    • 7.1.1 Overview
    • 7.1.2 Non-Invasive Ventilation Disposable Mask: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Non-Invasive Ventilation Reusable Mask
    • 7.2.1 Overview
    • 7.2.2 Non-Invasive Ventilation Reusable Mask: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Europe Non-Invasive Ventilation Masks Market Analysis - by Application

  • 8.1 Sleep Apnea
    • 8.1.1 Overview
    • 8.1.2 Sleep Apnea: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Chronic Obstructive Pulmonary Disease
    • 8.2.1 Overview
    • 8.2.2 Chronic Obstructive Pulmonary Disease: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.3 Pneumonia
    • 8.3.1 Overview
    • 8.3.2 Pneumonia: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.4 Others
    • 8.4.1 Overview
    • 8.4.2 Others: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Europe Non-Invasive Ventilation Masks Market Analysis - by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Overview
    • 9.1.2 Hospitals and Clinics: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.2 Home Care
    • 9.2.1 Overview
    • 9.2.2 Home Care: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.3 Others
    • 9.3.1 Overview
    • 9.3.2 Others: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Europe Non-Invasive Ventilation Masks Market - Country Analysis

  • 10.1 Europe
    • 10.1.1 Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.1 Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.2 United Kingdom: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.2.1 United Kingdom: Europe Non-Invasive Ventilation Masks Market Share - by Product
        • 10.1.1.2.2 United Kingdom: Europe Non-Invasive Ventilation Masks Market Share - by Application
        • 10.1.1.2.3 United Kingdom: Europe Non-Invasive Ventilation Masks Market Share - by End User
      • 10.1.1.3 Germany: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.3.1 Germany: Europe Non-Invasive Ventilation Masks Market Share - by Product
        • 10.1.1.3.2 Germany: Europe Non-Invasive Ventilation Masks Market Share - by Application
        • 10.1.1.3.3 Germany: Europe Non-Invasive Ventilation Masks Market Share - by End User
      • 10.1.1.4 France: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.4.1 France: Europe Non-Invasive Ventilation Masks Market Share - by Product
        • 10.1.1.4.2 France: Europe Non-Invasive Ventilation Masks Market Share - by Application
        • 10.1.1.4.3 France: Europe Non-Invasive Ventilation Masks Market Share - by End User
      • 10.1.1.5 Italy: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.5.1 Italy: Europe Non-Invasive Ventilation Masks Market Share - by Product
        • 10.1.1.5.2 Italy: Europe Non-Invasive Ventilation Masks Market Share - by Application
        • 10.1.1.5.3 Italy: Europe Non-Invasive Ventilation Masks Market Share - by End User
      • 10.1.1.6 Spain: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.6.1 Spain: Europe Non-Invasive Ventilation Masks Market Share - by Product
        • 10.1.1.6.2 Spain: Europe Non-Invasive Ventilation Masks Market Share - by Application
        • 10.1.1.6.3 Spain: Europe Non-Invasive Ventilation Masks Market Share - by End User
      • 10.1.1.7 Rest of Europe: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.7.1 Rest of Europe: Europe Non-Invasive Ventilation Masks Market Share - by Product
        • 10.1.1.7.2 Rest of Europe: Europe Non-Invasive Ventilation Masks Market Share - by Application
        • 10.1.1.7.3 Rest of Europe: Europe Non-Invasive Ventilation Masks Market Share - by End User

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Noninvasive Ventilation Mask Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Hamilton Medical AG
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 ResMed Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Fisher & Paykel Healthcare Corp Ltd
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Air Liquide Medical Systems
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Dragerwerk AG & Co KGaA
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Intersurgical Ltd
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 BMC Medical Co Ltd
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 DeVilbiss Healthcare LLC
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Armstrong Medical Ltd
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Koninklijke Philips NV
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Besmed Health Business Corp
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments
  • 12.12 Sleepnet Corporation.
    • 12.12.1 Key Facts
    • 12.12.2 Business Description
    • 12.12.3 Products and Services
    • 12.12.4 Financial Overview
    • 12.12.5 SWOT Analysis
    • 12.12.6 Key Developments
  • 12.13 SunMed Group Holdings LLC ( AirLife)
    • 12.13.1 Key Facts
    • 12.13.2 Business Description
    • 12.13.3 Products and Services
    • 12.13.4 Financial Overview
    • 12.13.5 SWOT Analysis
    • 12.13.6 Key Developments
  • 12.14 Dimar S.P.A.
    • 12.14.1 Key Facts
    • 12.14.2 Business Description
    • 12.14.3 Products and Services
    • 12.14.4 Financial Overview
    • 12.14.5 SWOT Analysis
    • 12.14.6 Key Developments
  • 12.15 Hangzhou Formed Medical Devices Co., Ltd
    • 12.15.1 Key Facts
    • 12.15.2 Business Description
    • 12.15.3 Products and Services
    • 12.15.4 Financial Overview
    • 12.15.5 SWOT Analysis
    • 12.15.6 Key Developments
  • 12.16 SURU INTERNATIONAL PVT. LTD.
    • 12.16.1 Key Facts
    • 12.16.2 Business Description
    • 12.16.3 Products and Services
    • 12.16.4 Financial Overview
    • 12.16.5 SWOT Analysis
    • 12.16.6 Key Developments
  • 12.17 Medline Industries LP
    • 12.17.1 Key Facts
    • 12.17.2 Business Description
    • 12.17.3 Products and Services
    • 12.17.4 Financial Overview
    • 12.17.5 SWOT Analysis
    • 12.17.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 List of Abbreviations